Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Published:2009-02-26 Issue:1 Volume:27 Page:152-157
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Kaya Ali Osman, ,Buyukberber Suleyman,Benekli Mustafa,Coskun Ugur,Sevinc Alper,Akmansu Muge,Yildiz Ramazan,Ozturk Banu,Yaman Emel,Kalender Mehmet Emin,Orhan Okan,Yamac Deniz,Uner Aytug

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-009-9186-z.pdf

Reference22 articles.

1. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311:899–909.

2. Furuse K, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol. 1999;17:2692–9.

3. Curran WJ, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol. 2003;22:121. (Abstract 2499).

4. Kiura K, et al. Phase I/II study docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer. Br J Cancer. 2003;89:795–802.

5. Albain KS, et al. Phase III study of concurrent chemotherapy, radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA (pN2) non-small-cell lung cancer: outcomes update of North Amrica Interfgroup 0139 (RTOG 9309). J Clin Oncol. 2005;23:7014.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SpaRx: elucidate single-cell spatial heterogeneity of drug responses for personalized treatment;Briefings in Bioinformatics;2023-09-22

2. SpaRx: Elucidate single-cell spatial heterogeneity of drug responses for personalized treatment;2023-08-06

3. The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update;Expert Review of Respiratory Medicine;2016-10-03

4. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with non-small-cell lung cancer: a study of 2062 cases;The British Journal of Radiology;2015-12

5. Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung;Supportive Care in Cancer;2014-08-16